SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF

NCT05852704 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Chronic Coronary Syndrome
Atrial Fibrillation

Interventions

DRUG: Dapagliflozin 10mg Tab
DRUG: Placebo Tab

Sponsor

Region Örebro County

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]